This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Verus Pharmaceuticals grosses $78mm with first venture round
30 Jun 2005
Pediatric specialty drug company Verus Pharmaceuticals has raised $78mm with its Series A venture round of preferred shares led by Domain Associates and Prospect Venture Partners. Other backers included the Paul Royalty Fund (managed by Paul Capital Partners), MPM Capital, Montreux Equity Partners, Athenian Venture Partners, Windamere, and private investors. Paul Royalty provided an additional $20mm in exchange for royalties on at least one undisclosed product.
Already a Biomedtracker subscriber?You have access to the full deal record through your subscription
Want to become a subscriber?Subscribers get more deal details, updates, deal financials and deal products.Questions?